The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.
This information will be published on the database - Disclosure UK.
Disclosure UK database
Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
Explore the data further
As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.
Methodological notes by company and year
Disclosure UK is an industry-led initiative to deliver a searchable database that shows payments and benefits in kind made by the pharmaceutical industry to doctors, nurses and other health professionals and organisations in the UK.
The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.
The ABPI is committed to protecting and respecting the privacy of your personal data. This privacy notice explains how your data is collected, used, transferred and disclosed by us.
Disclosure UK publications
-
Healthcare professionals: Step up to Disclosure UK
Disclosure UK leaflet for healthcare professionals encouraging transparency. Co-branded with other professional healthcare bodies.
-
Gweithwyr gofal iechyd proffesiynol: Camwch i fyny i Disclosure UK
Heddiw mae cleifion, y cyhoedd, archwilwyr a’r cyfryngau yn disgwyl i’r sector gofal iechyd fod yn agored ynghylch eu cydweithrediadau. Mae Disclosure UK yn eich helpu i fod yn dryloyw ynghylch eich rhyngweithio â chwmnïau fferyllol.
-
NHSE/ABPI joint letter on disclosure
The ABPI and NHS England have issued a joint letter setting out the ambition to increase consent rates as quickly as possible for publication of payments to individuals on Disclosure UK.
-
Disclosure UK – GDPR Factsheet
The General Data Protection Regulation (GDPR) is a set of new, Europe-wide data protection rules which come into effect on 25 May 2018.
-
What is R&D?
Pharmaceutical company research and development activities on Disclosure UK
-
Disclosure UK FAQs
Answers to the frequently asked questions about Disclosure UK
-
How we work with HCOs
Factsheet on how and why the pharmaceutical industry works with healthcare organisations
-
How we work with HCPs
Factsheet on how and why the pharmaceutical industry works with healthcare professionals
-
About Disclosure UK poster (A1)
A1-sized poster explaining Disclosure UK and the history of transparency
-
About Disclosure UK
Leaflet explaining Disclosure UK
-
About Disclosure UK poster (A0)
A0-sized poster explaining Disclosure UK and the history of transparency
-
Temporary changes to publication of 2019 disclosure data
Technical statement and Q&A on the temporary change to 2019 disclosure data as a result of the COVID-19 pandemic.